SEC 13F Intelligence

Boxer Capital, LLC / TYRA

Boxer Capital, LLC’s Tyra Biosciences Inc Position

Does Boxer Capital, LLC own Tyra Biosciences Inc (TYRA)? Not currently — the last reported position was 6.45M shares worth $152M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$152M
Q3 2024
Shares
6.45M
% of Portfolio
+7.44%
Quarters Held
13
position exited

Position History TYRA

Reported value by quarter
Q3 ’21: $111MQ3 ’21Q4 ’21: $91MQ1 ’22: $69MQ1 ’22Q2 ’22: $46MQ3 ’22: $57MQ3 ’22Q4 ’22: $49MQ1 ’23: $103,625Q1 ’23Q2 ’23: $109,816Q3 ’23: $89MQ3 ’23Q4 ’23: $89MQ1 ’24: $106MQ1 ’24Q2 ’24: $103MQ3 ’24: $152MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20246.45M$152M+7.44%
Q2 20246.45M$103M+5.43%
Q1 20246.45M$106M+5.22%
Q4 20236.45M$89M+4.45%
Q3 20236.45M$89M+4.73%
Q2 20236.45M$109,816+5.09%
Q1 20236.45M$103,625+5.09%
Q4 20226.45M$49M+2.58%
Q3 20226.45M$57M+3.19%
Q2 20226.45M$46M+2.92%
Q1 20226.45M$69M+3.55%
Q4 20216.45M$91M+3.52%
Q3 20216.32M$111M+3.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of TYRA.